ICER produced a comprehensive white paper on diagnostic testing for Alzheimer’s disease that was presented to the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).

Date of review: January 2013

For questions, contact

Intervention of interest: Diagnostics for Alzheimer’s disease

Final Documents

Below you will find the final documents from the policy paper review process: